# R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL

> **NCT01148446** · PHASE3 · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 226 (actual)

## Conditions studied

- Elderly Patients (>65 Years)
- Diffuse Large B Cell Lymphoma (DLBCL)

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Cyclophosphamide
- **DRUG:** Doxorubicin
- **DRUG:** Vincristine
- **DRUG:** Prednisone
- **DRUG:** Prednisone
- **DRUG:** Epirubicin
- **DRUG:** Vinblastine
- **DRUG:** Rituximab
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT01148446
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2010-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148446, "R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01148446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*